Newpath Partners closed its second fund with a $350 million raise, to continue its model of backing scientist-entrepreneurs during the earliest stages of company formation. The Boston-based firm works closely with a tight circle of influential scientific leaders to establish firms with high levels of scientific originality – and high ambitions to match.